Loading...
RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
INTRODUCTION: Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorigenesis in medullary thyroid carcinom...
Na minha lista:
| Udgivet i: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333032/ https://ncbi.nlm.nih.gov/pubmed/25546157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4153 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|